MECHANISMS
A network of vascular mechanisms
Sulodexide is best investigated as a vascular-interface modulator rather than reduced to one pharmacological label. Ten interacting research areas make up the map — every node is a link to its explanation.
Antithrombin III
The fast-moving heparin-like fraction shows affinity for antithrombin III, the endogenous serine-protease inhibitor that regulates coagulation proteases. This is the classical pharmacology of the principal fraction.
Heparin cofactor II
Dermatan sulfate interacts with heparin cofactor II, a second endogenous serine-protease inhibitor. The two fractions therefore engage two different endogenous anticoagulant systems.
Thrombin regulation
Through both cofactor pathways, sulodexide participates in thrombin regulation. Regulation is the accurate word: published pharmacology does not describe clotting being completely disabled.
Fibrinolytic balance
Profibrinolytic properties have been described in the literature, involving the balance of fibrin formation and clearance. Sulodexide must never be portrayed as instantly dissolving established clots.
Endothelial glycocalyx
Human mechanistic research reported changes in measured glycocalyx dimensions; experimental work reports permeability improvements via glycocalyx remodelling. Evidence exists alongside continuing uncertainty about mechanism, magnitude and clinical meaning.
Nitric oxide
Isolated vascular-tissue experiments showed endothelium-dependent, nitric-oxide-mediated relaxation. These are vascular-tissue experiments — not proof of a clinical blood-pressure treatment.
Inflammatory signalling
Endothelial inflammatory signalling intersects with glycocalyx state, permeability and coagulation. Biomarker studies — including convalescent COVID-19 research — measured inflammatory mediators among their endpoints.
Vascular permeability
Barrier behaviour is a recurring endpoint: transcapillary albumin escape in human mechanistic work, and permeability assays in cell and animal models. Preclinical findings do not translate automatically into human efficacy.
Matrix metalloproteinases
MMP-2 and MMP-9 participate in extracellular-matrix turnover and venous pathology. Sulodexide research has touched matrix-remodelling pathways relevant to chronic venous disease.
Extracellular matrix
The extracellular matrix is the structural context in which the endothelium lives. Matrix biology connects sulodexide research to tissue mechanics, remodelling and the wider vascular-repair question.